All In Biotech

Drug Trial Radar · NCT05018221

Better Evidence and Translation for Calciphylaxis

Last checked: Nov 19, 2026Latest source record: Aug 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Aug 26, 2021

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
University of SydneyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Australasian Kidney Trials Network; Northern Care Alliance NHS Foundation Trust; Waitemata District Health Board; Vantive Health LLC; Berry Consultants
First posted
Aug 24, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This global platform study will evaluate multiple interventions, across several domains of therapeutic care, in adult patients with kidney failure and newly diagnosed calciphylaxis.

Conditions

  • Calciphylaxis

Interventions

  • Vitamin K1Drug

    Vitamin K1 capsule (10mg) to be administered 3 times per week following the subject's hemodialysis session.

  • Magnesium citrateDrug

    Magnesium Citrate tablet (150mg) to be administered 3 times per per day. On dialysis days, administration of the middle daily dose should occur following the subject's hemodialysis session.

  • Sodium ThiosulfateDrug

    Sodium Thiosulfate injection (25g/100ml) to be administered intravenously 3 times per week, during the subject's last hour of hemodialysis.

  • High Flux DialyserDevice

    Hemodialysis using a high flux dialyser.

  • Medium Cut-off DialyserDevice

    Hemodialysis using a medium cut-off dialyser.

  • Placebo injection (normal saline)Drug

    Placebo to be administered intravenously 3 times per week, during the subject's last hour of hemodialysis.

  • Placebo capsule (Vitamin K1)Drug

    Placebo to be administered 3 times per week following the subject's hemodialysis session.

  • Placebo tablet (Magnesium citrate)Drug

    Placebo to be administered 3 times per day. On dialysis days, administration of the middle daily dose should occur following the subject's hemodialysis session.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. BEAT-Calci Wound Assessment Scale (BCWAS) - Baseline to Week 12Time frame: Week 12

Locations

21 sites in 2 countries. Site status is shown where the registry gives one.

  • Royal Adelaide Hospital

    Adelaide, Australia · Recruiting

  • Monash Medical Centre

    Clayton, Australia · Recruiting

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia · Recruiting

  • St George Hospital

    Kogarah, New South Wales, Australia · Recruiting

  • Liverpool Hospital

    Liverpool, New South Wales, Australia · Recruiting

  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Sunshine Coast Hospital and Health Service

    Birtinya, Queensland, Australia · Recruiting

  • Princess Alexandra Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Bundaberg Base Hospital

    Bundaberg, Queensland, Australia · Recruiting

  • Cairns Hospital

    Cairns, Queensland, Australia · Recruiting

  • Townsville Hospital

    Douglas, Queensland, Australia · Recruiting

  • Ipswich Hospital

    Ipswich, Queensland, Australia · Recruiting

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Sunshine Hospital (Western Health)

    St Albans, Victoria, Australia · Recruiting

  • Royal Perth Hospital

    Perth, Western Australia, Australia · Recruiting

  • Dunedin Hospital

    Dunedin, New Zealand · Recruiting

  • Auckland City Hospital (Auckland DHB)

    Grafton, New Zealand · Recruiting

  • North Shore Hospital (Waitemata DHB)

    Takapuna, New Zealand · Recruiting

  • Tauranga Hospital

    Tauranga, New Zealand · Recruiting

  • Whangarei Hospital

    Whangarei, New Zealand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.